Market Players Focus on Addressing Challenges Put Forward by Current Stent Modalities

Due to consistent advancements in the cardiovascular medicine field, stenting of the arteries has emerged as one of the most common and popular cardiovascular treatment. As stenting continues to gain popularity across the world, the demand for vascular stents continues to gain considerable traction. The alarming rise in the number of patients suffering from cardiovascular diseases has compelled the medical sector to focus on new treatments and medical concepts to improve the recovery rate of existing treatments. At present, existing technologies, particularly related to drug-eluting stents have witnessed rapid developments.

In addition, due to added research, these technologies continue to demonstrate high levels of efficacy and low rate of treatment failure due to which, applications of vascular stents continue to expand at a promising rate– a leading factor that is expected to drive the vascular stents market during the forecast period. Over the past few decades, participants operating in the vascular stents market are increasingly focusing on minimizing various complications involved with vascular stent implantations such as local chronic inflammation, in-stent restenosis, re-occlusion rates, and late thrombosis.

Considerable emphasis is being laid on various parameters of vascular stent development to facilitate long-term stability and assess various failure mechanisms. Currently, vascular stent technologies primarily focus on addressing the restenosis rate of high-risk patients in both, bare-metal stents as well as drug-eluting stents. At the back of these factors, along with growing demand for minimally invasive therapies, the global vascular stents market is expected to reach ~US$ 12 Bn by the end of 2027.

To know the scope of our report Get a Sample on Vascular Stents Market 

Drawbacks of First-generation Vascular Stents Result in Development of Advanced Products

The first-generation of vascular stents that were predominantly fabricated from cobalt-chromium, platinum-iridium, and stainless steel put forward an array of problems that led to tissue hyperplasia. Shortcomings and several other minor drawbacks of the first-generation of vascular stents accelerated the production of drug-eluting stents, biodegradable stents, and coated stents. Several vascular stent manufacturers are increasingly prioritizing the optimization of the physical-chemical, biological, and mechanical stent properties to attain the desired characteristics of various stents.

Some of the major developments and fabrication technologies in the vascular stents market are likely to focus on various properties, including expandability ration, compatibility with a balloon catheter, magnetic resonance imaging, flexibility, and thromboresistivity. The high mortality rate associated with cardiovascular diseases around the world coupled with innovative stent technology concepts has prompted clinicians and researchers to focus on the development of new techniques, materials, and solutions to enhance the clinical outcome of the currently deployed vascular stents.

Bioresorbable and Integrated Biosensor Technology to Redefine Future of Vascular Stents

As cardiovascular diseases continue to be among the leading causes of death around the world, consistent efforts are being made to address this looming medical problem. The existing anti-atherosclerotic and pharmacological modalities still fall short in controlling the disease due to which, enhancements in clinical interventions is the need of the hour. As a result of research, experts in the healthcare sector are of the opinion that bio-sensing devices offer immense promise in addressing in-stent restenosis. Moreover, due to the progress in nanofabrication, researchers continue to explore the various ways in which biosensors can be integrated into vascular stents to address the shortcomings of the existing stent modalities.

Get a glimpse of the in-depth analysis through our Report Brochure

The “Internet of Things” is expected to play a major role in the development of the next-generation of vascular stents. One of the recent developments across the vascular stents market that have gained considerable spotlight is the onset of bioresorbable stents. Analysts at Transparency Market Research predict that the adoption of bioresorbable stents is likely to witness considerable growth over the course of the forecast period due to the limitations of metal stents.

Demand to Fluctuate amid COVID-19 Pandemic, Product Diversification May Provide Short-term Gains

As the ongoing COVID-19 pandemic continues to derail the global economic growth, the medical sector continues to witness considerable movement. While the demand for personal protective equipment and other medical medicines and devices required for the treatment of the novel COVID-19 coronavirus is expected to skyrocket, the demand for vascular stents is likely to fluctuate due to lack of information regarding the potential impact of the virus on heart patients.

Several studies have suggested that individuals suffering from cardiovascular diseases are at a higher risk of contracting COVID-19 infection. While government regulations and guidelines continue to prioritize trade of COVID-19 medication and devices, the demand for vascular stents is likely to remain steady. Although it is hard to predict the demand pattern due to several external factors, the vascular stents market is expected to witness a lower growth rate compared with that of 2019.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global vascular stents market is expected to grow at a moderate CAGR of ~5% during the forecast period. The considerable rise in the number of patients suffering from cardiovascular diseases, research & development activities, focus on improving the efficacy of existing stent technologies, and focus on the production of cutting-edge stents integrated with biosensors are some of the leading factors that will provide a boost to the growth of the vascular stents market during the forecast period. Market players should focus on research and development of new vascular stents that offer improved performance in comparison with first-generation stents fabricated from stainless steel and other metals. Biodegradable stents are likely to gain popularity in the upcoming years and could potentially replace vascular stents fabricated from metals.

Vascular Stents Market: Overview

  • This report analyzes the current and future prospects of the global vascular stents market. Rise in prevalence of cardiovascular diseases and increase in demand for minimally invasive surgeries are the key factors fueling the growth of the global vascular stents market during the forecast period.
  • The report provides an elaborate executive summary, which comprises a snapshot of various segments of the global vascular stents market. The report also provides information and data analysis of the global vascular stents market with regard to segments based on type, delivery method, material, end user, and region.
  • The overview section of the report provides detailed qualitative analysis of drivers and restraints impacting the global vascular stents market along with opportunities in the global market
  • Additionally, the global vascular stents market report includes company profiles and competitive matrix, which provide data about their businesses, product portfolios, and competitive landscape in the global vascular stents market
  • The report includes data analysis on the vascular stents market attractiveness by region and segments
  • The last section of the report provides quantitative and qualitative analysis on market share of key players operating in the global vascular stents market. It elaborates the key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global vascular stents market.

Vascular Stents Market: Key Segments

  • In terms of type, the global vascular stents market has been segmented into coronary artery stents, peripheral vascular stents, and neurovascular stents. The coronary artery stents segment has been sub-segmented into bare metal stents, bioresorbable stents, covered stents, and drug eluting stents. The peripheral vascular stents segment has been split into fem-pop artery stents, iliac artery stents, and infrapop artery stents. The coronary artery stents segment held a major share of the global vascular stents market in 2018.
  • In terms of delivery method, the global vascular stents market has been classified into balloon expandable stents and self-expanding stents. The self-expanding stents segment is likely to dominate the global vascular stents market during the forecast period.
  • Based on material, the global vascular stents has been divided into cobalt-chromium stent, platinum-chromium stent, nitinol stent, stainless steel stent, and bioresorbable polymer stent
  • In terms of end user, the global vascular stents market has been categorized into hospitals, cardiac centers, and ambulatory surgical centers. The hospital segment is projected to dominate the global vascular stents market during the forecast period.
  • The market size and forecast for each of these segments have been provided from 2017 to 2027. The CAGR of respective segment has also been provided for the forecast period from 2019 to 2027, considering 2018 as the base year.

Vascular Stents Market: Regional Outlook

  • In terms of region, the global vascular stents market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa)
  • The report provides market size and forecast for each region and country/sub-region from 2017 to 2027. Compound annual growth rates (CAGRs) of each of these regions and countries have also been provided for the forecast period from 2019 to 2027, considering 2018 as the base year. The vascular stents market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • Key players in the global vascular stents market have been profiled based on key aspects such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global vascular stents market report 
    • Abbott Vascular (Abbott Laboratories)
    • Cordis Corporation (A Cardinal Health Company)
    • Medtronic
    • Boston Scientific Corporation
    • BIOTRONIK AG
    • Lifetech Scientific
    • C. R. Bard, Inc. (Becton, Dickinson and Company)
    • Biosensors International Group, Ltd.
    • Cook Medical,
    • W. L. Gore & Associates, Inc.

Vascular Stents Market – Scope of the Report

TMR’s report on the vascular stents market studies the past as well as the current growth trends and opportunities, to gain valuable insights of these indicators for the market over the forecast period from 2019 to 2027. The report provides the overall revenue of the global vascular stents market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global vascular stents market for the forecast period 2019–2027.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the vascular stents market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approach to study various phenomena in the vascular stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the vascular stents market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the vascular stents market.

The report also delves into the competition landscape of the vascular stents market. Key players operating in the vascular stents market are identified and each one of these is profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the vascular stents market that are profiled in this report.

Key Questions Answered in Vascular Stents Market Report

  • How does the development of vascular stents provide scope of growth in the vascular stents market?
  • How alliances and partnerships between players are widening the scope of new line of technologies for vascular stents?
  • What are the revenue share projections of key segments under various criteria in the vascular stents market during the forecast period?
  • Which segment is likely to register leading revenue until the end of the forecast period in 2027?
  • How is the evolving health care system in developing countries of Asia Pacific making an impact on the overall vascular stents market?

Vascular Stents Market - Research Objectives and Research Approach

The comprehensive report on the vascular stents market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for vascular stents.

For reading comprehensibility, the report is compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the vascular stents market in terms of type, delivery method, material, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2027 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the vascular stents market.

Vascular Stents Market - Segmentation

Type

Coronary Artery Stents

  • Bare Metal Stents
  • Bioresorbable Stents
  • Covered Stents
  • Drug Eluting Stents

Peripheral Vascular Stents

  • Fem-pop Artery Stents
  • Iliac Artery Stents
  • Infrapop Artery Stents

Neurovascular Stents

 

Delivery Method

Balloon Expandable Stents

Self-expanding Stents

Material

Cobalt-Chromium Stent

Platinum-Chromium Stent

Nitinol Stent

Stainless Steel Stent

Bioresorbable Polymer Stent

End User

Hospitals

Cardiac Centers

Ambulatory Surgical Centers

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Vascular Stents Market

Buy Now